Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 1, 2013, Pages

  Bryniarski, Krzysztof ^a   Ptak, Wlodzimierz ^a   Jayakumar, Asha ^b   Püllmann, Kerstin ^c   Caplan, Michael J ^b   Chairoungdua, Arthit ^b   Lu, Jun ^b   Adams, Brian D ^b   Sikora, Emilia ^a   Nazimek, Katarzyna ^a   Marquez, Susanna ^b   Kleinstein, Steven H ^b   Sangwung, Panjamaporn ^d   Iwakiri, Yasuko ^d   Delgato, Eric ^b   Redegeld, Frank ^e   Blokhuis, Bart R ^e   Wojcikowski, Jacek ^f   Daniel, Anna Wladyslawa ^f   Kormelink, Tom Groot ^b   Askenase, Philip W ^b   more..

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^d YALE UNIVERSITY   (United States)

^e UTRECHT UNIVERSITY   (Netherlands)

^f POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Allergic cutaneous contact dermatitis; Antibody light chains; Contact sensitivity; Exosome like nanovesicles; Exosomes; MiRNA; MiRNA 150; Nanovesicles; T cell suppression

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; MICRORNA; MICRORNA 150; OXAZOLONE; TRINITROPHENYLHAPTEN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BIOASSAY; BIOINFORMATICS; CELL CULTURE; CELL ISOLATION; CELL SURFACE; CONTACT SENSITIVITY; CONTROLLED STUDY; DONOR; ELECTRON MICROSCOPY; ERYTHROCYTE; EXOSOME; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LIGHT CHAIN; LYMPH NODE; MOLECULAR CLONING; MOUSE; NANOVESICLE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; SUPERNATANT; SUPPRESSOR CELL; T LYMPHOCYTE;

EID: 84882869840     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.04.048     Document Type: Article

References (101)

1. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009;9:581-93.
2. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006;Chapter 3:Unit 3.22.
3. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-me-diated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-9.
4. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10:1470-6.
5. Korkut C, Ataman B, Ramachandran P, Korkut C, Ashley J, Barria R, et al. Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless. Cell 2009; 139:393-404.
6. Koles K, Nunnari J, Korkut C, Barria R, Brewer C, Li Y, et al. Mechanism of evenness interrupted (evi)-exosome release at synaptic moutons. J Biol Chem 2012;287:16820-34.
7. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of betacatenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol 2010; 190:1079-91.
8. Zhang J, Luo N, Luo Y, Peng Z, Zhang T, Li S. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int J Oncol 2012;40:747-56.
9. Zhang L, Hou D, Chen X, Li D, Zhu L, Zhang Y, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 2012;22:107-26.
10. Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, Durr C, et al. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity J Exp Med 2008;205:2151-62.
11. Askenase PW, Szczepanik M, Itakura A, Kiener C, Campos RA. Extravascular T cell recruitment requires initiation begun by V14+ NKT cells and B-1 B cells. Trends Immunol 2004;25:441-9.
12. Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J, Cha-vagnac C, et al. CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol 2006;126:815-20.
13. Lee DS, Gulati N, Martiniuk F, Levis WR. CD70 and Th17 are involved in human contact sensitivity. J Drugs Dermatol 2011;10:1192-4.
14. Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, Senman B, et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 2010;11:1127-35.
15. Simonetta F, Chiali A, Cordier C, Urrutia A, Girault I, Bloquet S, et al. Increased CD127 expression on activated FOXP3+CD4+ regulatory cells. Eur J Immunol 2010;40:2528-38.
16. Ilkovitch D. Role of immune-regulatory cells in skin pathology. J Leukoc Biol 2011;89:41-9.
17. Choudhuri K, Llodra J, Kam L, Stokes D, Dustin M. Antigen-induced release and retroviral subversion of TCR-enriched microvesicles at the CD4+ T cell immunological synapse. J Immunol 2012;188:58-65.
18. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, Gonzalez S, Sanchez-Cabo F, Gonzalez MA, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2011;2:282-91.
19. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, Karlsson JM, et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012;119:756-66.
20. Sahoo S, Klychko E, Thorne T, Misener S, Schultz KM, Millay M, et al. Exosomes from human CD34 (+) stem cells mediate their proangiogenic paracrine activity. Circ Res 2011;109:724-8.
21. Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJ, Zeiher AM, et al. Atheroprotective communication between endothelia cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012;14:249-56.
22. Lachenal G, Pernet-Gallay K, Chivet M, Hemming FJ, Belly A, Bodon G, et al. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci 2011;46:409-18.
23. Fitzner D, Schnaars M, van Rossum D, Krishnamoorthy G, Dibaj P, Bakhti M, et al. Selective transfer of exosomes from oligodendrocytes to microglia by mac-ropinocytosis. J Cell Sci 2011;124:447-58.
24. Eldh M, Ekstrom K, Valadi H, Sjostrand M, Olsson B, Jernas M, et al. Exosomes communicate protective messages during oxidative stress; possible role of exoso-mal shuttle RNA. PLoS One 2010;5:e15353.
25. Meckes DG Jr, Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci USA 2010;107:20370-5.
26. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hop-mans ES, Lindenberg JL, et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 2010;107:6328-33.
27. Soo CY, Song Y, Zheng Y, Campbell EC, Riches AC, Gun-Moore E, et al. Nano-particle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology 2012;136:192-7.
28. KaLahl K, Sparwasser T In vivo depletion of FoxP3+Tregs using the DEREG mouse model. Methods Mol Biol 2011;707:157-72.
29. Chen J, Trounstine M, Alt FW, Young F, Kurahara C, Loring JF, et al. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol 1993;5:647-56.
30. Redegeld FA, van der Heijden MW, Kool M, Heijdra BM, Garssen J, Kraneveld AD, et al. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat Med 2002;8:694-701.
31. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007;131:146-59.
32. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007;104:7080-5.
33. Bruchova-Votavova H, Yoon D, Prchal JT. MiR-451 enhances erythroid differentiation in K562 cells. Leuk Lymph 2010;51:686-93.
34. Hussein K, Theophile K, Busche G, Schlegelberger B, Gohring G, Kreipe H, et al. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. Leuk Res 2010;34:328-34.
35. Bezman NA, Chakraborty T, Bender T, Lanier LL. MiR-150 regulates the development of NK and iNKT cells. J Exp Med 2011;208:2717-31.
36. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood 2011;117:7053-62.
37. Zheng Q, Zhou L, Mi QS. MicroRNA miR-150 is involved in Valpha14 invariant NKT cell development and function. J Immunol 2012;188:2118-26.
38. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K, et al. Foxp3-Dependent MicroRNA155 confers competitive fitness to regulatory t cells by targeting SOCS1 protein. Immunity 2009;30:80-91.
39. Housden NG, Harrison S, Housden HR, Thomas KA, Beckingham JA, Roberts SE, et al. Observation and characterization of the interaction between a single immunoglobulin binding domain of protein L and two equivalents of human kappa light chains. J Biol Chem 2004;279:9370-8.
40. Powe DG, Groot Kormelink T, Sisson M, Blokhuis BJ, Kramer MF, Jones NS, et al. Evidence for the involvement of free light chain immunoglobulins in allergic and nonallergic rhinitis. J Allergy Clin Immunol 2010;125:139-45.
41. Groot Kormelink T, Calus L, De Ruyck N, Holtappels G, Bachert C, Redegeld FA, et al. Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps. Allergy 2012;67:1165-72.
42. Thio M, Groot Kormelink T, Fischer MJ, Blokhuis BR, Nijkamp F, Redegeld FA. Characteristics of immunoglobulin free light chains: crosslinking by antigen is essential to induce allergic inflammation. PLoS One 2012;7:e40986.
43. Groot Kormelink T, Askenase PW, Redegeld FA. Immunobiology of antigen-specific immunoglobulin free light chains in chronic inflammatory diseases. Curr Pharm Des 2012;18:2278-89.
44. Groot Kormelink T, Tekstra J, Thurlings RM, Boumans MH, Vos K, Tak PP, et al. Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity. Ann Rheum Dis 2010;69:2137-44.
45. Tekstra J, van Roon J, Groot Kormelink T, Redegeld F Immunoglobulin free lightchain levels and rituximab response in rheumatoid arthritis: comment on the article by Sellam et al. Arthritis Rheum 2011;63:4034-5.
46. Paliwal V, Tsuji RF, Szczepanik M, Kawikova I, Campos RA, Kneilling M, et al. Subunits of IgM reconstitute defective contact sensitivity in B-1 cell-deficient xid mice: kappa light chains recruit T cells independent of complement. J Immunol 2002; 169:4113-23.
47. Hutchinson AT, Jones DR, Raison RL. The ability to interact with cell membranes suggests possible biological roles for free light chain. Immunol Lett 2012;142: 75-7.
48. Almqvist N, Lonnqvist A, Hultkrantz S, Rask C, Telemo E. Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma. Immunology 2008;125:21-7.
49. Kim SH, Bianco N, Menon R, Lechman ER, Shufesky WJ, Morelli AE, et al. Exosomes derived from genetically modified DC expressing FasL are antiinflammatory and immunosuppressive. Mol Ther 2006;13:289-300.
50. Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD. MHC class II + exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner. J Immunol 2007;179:2235-41.
51. Prado N, Marazuela EG, Segura E, Fernandez-Garcia H, Villalba M, Thery C, et al. Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction. J Immunol 2008;181:1519-25.
52. Hedlund M, Stenqvist AC, Nagaeva O, Kjellberg L, Wulff M, Baranov V, et al. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol 2009;183:340-51.
53. Sabapatha A, Gercel-Taylor C, Taylor DD. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol 2006;56:345-55.
54. Taylor DD, Akyol S, Gercel-Taylor C. Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol 2006;176:1534-42.
55. Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, et al. Exosomes with immune modulatory features are present in human breast milk. J Immunol 2007;179:1969-78.
56. Hao S, Ye Z, Li F, Meng Q, Qureshi M, Yang J, et al. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. Exp Oncol 2006;28:126-31.
57. Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z. Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol 2008; 180: 7249-58.
58. Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent Immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 2010;120:457-71.
59. Yang C, Kim SH, Bianco NR, Robbins PD. Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. PLoS One 2011;6:e22517.
60. Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol 2011;187:676-83.
61. Cai Z, Yang F, Yu L, Yu Z, Jiang L, Wang Q, et al. Activated T cell exosomes promote tumor invasion via Fas signaling pathway. J Immunol 2012;188:5954-61.
62. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012;18:883-91.
63. Ptak W, Rozycka D, Rewicka M. Induction of suppressor cells and cells producing antigen-specific suppressor factors by haptens bound to self-carriers. Immun-obiology 1980;156:400-9.
64. Ptak W, Rosenstein RW, Gershon RK. Interactions between molecules (subfat-cors) released by different T cell sets that yield a complete factor with biological (suppressive) activity. Proc Natl Acad Sci USA 1982;79:2375-8.
65. Ptak W, Gershon RK, Rosenstein RW, Murray JH, Cone RE. Purification and characterization of TNP-specific immunoregulatory molecules produced by T cells sensitized by picrylchloride (PC1F). J Immunol 1983;131:2859-63.
66. Ferreri NR, Herzog WR, Askenase PW. Inhibition of IL-2-dependent proliferation by a prostaglandin-dependent suppressor factor. J Immunol 1993;150: 2102-11.
67. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K, et al. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011;25:1324-34.
68. Matsushima H, Takashima A. Bidirectional homing of Tregs between the skin and lymph nodes. J Clin Invest 2010;120:653-6.
69. Kemeny DM, Noble A, Holmes BJ, Diaz-Sanchez D, Lee TH. The role of CD81 T cells in immunoglobulin E regulation. Allergy 1995;50:9-14.
70. Suzuki M, Konya C, Goronzy JJ, Weyand CM. Inhibitory CD81 T cells in autoimmune disease. Hum Immunol 2008;69:781-9.
71. Jiang H, Canfield SM, Gallagher MP, Jiang HH, Jiang Y, Zheng Z, et al. HLA-E-restricted regulatory CD8(1) T cells are involved in development and control of human autoimmune type 1 diabetes. J Clin Invest 2010;120:3641-50.
72. Accapezzato D, Francavilla V, Paroli M, Casciaro M, Chircu LV, Cividini A, et al. Hepatic expansion of a virus-specific regulatory CD8(1) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004;113:963-72.
73. Buckheit RW 3rd, Salgado M, Silciano RF, Blankson JN. Inhibitory potential of subpopulations of CD81 T cells in HIV-1-infected elite suppressors. J Virol 2012;86:13679-88.
74. Tumne A, Prasad VS, Chen Y, Stolz DB, Saha K, Ratner DM, et al. Noncytotoxic suppression of human immunodeficiency virus type 1 transcription by exosomes secreted from CD81 T cells. J Virol 2009;83:4354-64.
75. Chiba T, Ohtani H, Mizoi T, Naito Y, Sato E, Nagura H, et al. Intraepithelial CD81 T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micro-metastasis. Br J Cancer 2004;91:1711-7.
76. Olson BM, Jankowska-Gan E, Becker JT, Vignali DA, Burlingham WJ, McNeel DG. Human prostate tumor antigen-specific CD81 regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J Immunol 2012;189:5590-601.
77. Ciubotariu R, Colovai AI, Pennesi G, Liu Z, Smith D, Berlocco P, et al. Specific suppression of human CD41 Th cell responses to pig MHC antigens by CD81CD28-regulatory T cells. J Immunol 1998;161:5193-202.
78. Gilliet M, Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002;195:695-704.
79. Chang CC, Zhang QY, Liu Z, Clynes RA, Suciu-Foca N, Vlad G. Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(1) T suppressor cells. J Immunol 2012;188:3042-52.
80. Van Kaer L. Comeback kids: CD8(1) suppressor T cells are back in the game. J Clin Invest 2010;120:3432-4.
81. Tutaj M, Szczepanik M. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta1 CD41 CD81 double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE). J Autoimmun 2007;28:208-15.
82. Jurynczyk M, Walczak A, Jurewicz A, Jesionek-Kupnicka D, Szczepanik M, Sel-maj K. Immune regulation of multiple sclerosis by transdermally applied myelin peptides. Ann Neurol 2010;68:593-601.
83. Chen J, Trounstine M, Alt FW, Young F, Kurahara C, Loring JF, et al. Immu-noglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol 1993;5:647-56.
84. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007;131:146-59.
85. KaLahl K, Sparwasser T. In vivo depletion of FoxP31Tregs using the DEREG mouse model. Methods Mol Biol 2011;707:157-72.
86. Redegeld FA, van der Heijden MW, Kool M, Heijdra BM, Garssen J, Kraneveld AD, et al. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat Med 2002;8:694-701.
87. Ptak W, Rozycka D, Rewicka M. Induction of suppressor cells and cells producing antigen-specific suppressor factors by haptens bound to self-carriers. Im-munobiology 1980;156:400-9.
88. Ptak W, Rosenstein RW, Gershon RK. Interactions between molecules (subfat-cors) released by different T cell sets that yield a complete factor with biological (suppressive) activity. Proc Natl Acad Sci USA 1982;79:2375-8.
89. Ptak W, Gershon RK, Rosenstein RW, Murray JH, Cone RE. Purification and characterization of TNP-specific immunoregulatory molecules produced by T cells sensitized by picrylchloride (PC1F). J Immunol 1983; 131:2859-63.
90. Paliwal V, Tsuji RF, Szczepanik M, Kawikova I, Campos RA, Kneilling M, et al. Subunits of IgM reconstitute defective contact sensitivity in B-1 cell-deficient xid mice: kappa light chains recruit T cells independent of complement. J Immunol 2002;169:4113-23.
91. Eldh M, Ekström K, Valadi H, Sjöstrand M, Olsson B, Jernas M, et al. Exo-somes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One 2010;5:e15353.
92. Meckes DG Jr, Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci USA 2010;107:20370-5.
93. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hop-mans ES, Lindenberg JL, et al. Functional delivery of viral miRNAs via exo-somes. Proc Natl Acad Sci USA 2010;107:6328-33.
94. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006;Chapter 3:Unit 3.22.
95. Soo CY, Song Y, Zheng Y, Campbell EC, Riches AC, Gun-Moore E, et al. Nano-particle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology 2012;136:192-7.
96. Ferreri NR, Herzog WR, Askenase PW. Inhibitionof IL-2- dependentproliferation by a prostaglandin-dependent suppressor factor. J Immunol 1993;150:2102-11.
97. Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Human tumor-derived exo-somes selectively impair lymphocyte responses to interleukin-2. Cancer Res 2007;67:7458-66.
98. Hafner M, Landgraf P, Ludwig J, Rice A, Ojo T, Lin C, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008;44:3-12.
99. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10:R25.
100. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010;26:139-40.
101. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acid Res 2012;40:D1241-4.